Conserved CDR3 Regions in T-cell Receptor (TCR) CD8(+) T Cells That Recognize the Tax11-19/HLA-A*0201 Complex in a Subject Infected with Human T-cell Leukemia Virus Type 1: Relationship of T-cell Fine Specificity and Major Histocompatibility...
Overview
Affiliations
We investigated the T-cell receptor (TCR) repertoire of CD8(+) T cells that recognize the Tax11-19 immunodominant epitope of Tax protein expressed by human T-cell leukemia virus (HTLV-1) that is implicated in the disease HTLV-1-associated myelopathy (HAM/TSP). A panel of Tax11-19-reactive CD8(+) T-cell clones was generated by single-cell cloning of Tax11-19/HLA-A*0201 tetramer-positive peripheral blood lymphocytes from an HTLV-1-infected individual. The analyses of TCR usage revealed that the combination of diverse TCR alpha and beta chains could be used for the recognition of Tax11-19 but the major population of T-cell clones (15 of 24 clones) expressed the TCR V beta 13S1 and V alpha 17 chain. We found striking similarities in CDR3 regions of TCR alpha and beta chains between our major group of CD8(+) T-cell clones and those originating from different subjects as previously reported, including TCRs with resolved crystal structures. A 3-amino-acid sequence (PG-G) in the CDR3 region of the V beta chain was conserved among all the Tax11-19-reactive T-cell clones expressing V beta 13S1 and V alpha 17 chains. Conserved amino acids in the CDR3 region do not directly contact the Tax11-19 peptide, as corroborated by the crystal structure of B7-TCR, a TCR that is almost identical to VB13S1 clones isolated in this study. Analysis of fine peptide specificity using altered peptide ligands (APL) of Tax11-19 revealed a similar recognition pattern among this panel of T-cell clones. These data suggest that the PG-G amino acids in the CDR3 beta loop provide a structural framework necessary for the maintenance of the tertiary TCR structure.
Load-based divergence in the dynamic allostery of two TCRs recognizing the same pMHC.
Chang-Gonzalez A, Akitsu A, Mallis R, Lang M, Reinherz E, Hwang W bioRxiv. 2024; .
PMID: 39464111 PMC: 11507873. DOI: 10.1101/2024.10.16.618634.
Callery E, Morais C, Taylor J, Challen K, Rowbottom A Diagnostics (Basel). 2024; 14(20).
PMID: 39451653 PMC: 11507081. DOI: 10.3390/diagnostics14202330.
Identification and tracking of HTLV-1-infected T cell clones in virus-associated neurologic disease.
Nozuma S, Matsuura E, Tanaka M, Kodama D, Matsuzaki T, Yoshimura A JCI Insight. 2023; 8(7).
PMID: 37036006 PMC: 10132145. DOI: 10.1172/jci.insight.167422.
T cell receptor repertoire analysis in HTLV-1-associated diseases.
Clauze A, Enose-Akahata Y, Jacobson S Front Immunol. 2022; 13:984274.
PMID: 36189294 PMC: 9520328. DOI: 10.3389/fimmu.2022.984274.
Tanaka Y, Sato T, Yagishita N, Yamauchi J, Araya N, Aratani S Front Immunol. 2022; 13:993025.
PMID: 36081501 PMC: 9446235. DOI: 10.3389/fimmu.2022.993025.